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KSR1 is a mitogen-activated protein (MAP) kinase scaffold that enhances the activation of the MAP kinase
extracellular signal-regulated kinase (ERK). The function of KSR1 in NK cell function is not known. Here we
show that KSR1 is required for efficient NK-mediated cytolysis and polarization of cytolytic granules. Single-
cell analysis showed that ERK is activated in an all-or-none fashion in both wild-type and KSR1-deficient cells.
In the absence of KSR1, however, the efficiency of ERK activation is attenuated. Imaging studies showed that
KSR1 is recruited to the immunological synapse during T-cell activation and that membrane recruitment of
KSR1 is required for recruitment of active ERK to the synapse.
Kinase suppressor of Ras was originally identified in Dro-
sophila melanogaster (53) and Caenorhabditis elegans (19, 32,
52) as a positive regulator of the extracellular signal-regulated
kinase (ERK) mitogen-activated protein (MAP) kinase signal-
ing pathway. It is thought to function as a MAP kinase scaffold
because it can bind to Raf, MEK, and ERK (18, 19, 27, 28, 44,
59). While the exact function of KSR is unknown, preassem-
bling the three components of the ERK MAP kinase cas-
cade could function to enhance the efficiency of ERK acti-
vation, potentially regulate the subcellular location of ERK
activation, and promote access to specific subcellular sub-
strates (16, 45, 46).
While only one isoform of KSR is expressed in Drosophila
(53), two KSR isoforms have been identified in C. elegans (19,
32, 52) and most higher organisms. They are referred to as
KSR1 and KSR2 (32, 43). While KSR1 mRNA and protein are
detectable in a wide variety of cells and tissues, including brain,
thymus, and muscle (10, 11, 29), little is known about the
expression pattern of KSR2.
We previously reported the phenotype of KSR1-deficient
mice (30). These mice are born at Mendelian ratios and de-
velop without any obvious defects. Using gel filtration, we
showed that KSR1 promotes the formation of large signaling
complexes containing KSR1, Raf, MEK, and ERK (30). Using
both primary T cells stimulated with antibodies to the T-cell
receptor as well as fibroblasts stimulated with growth factors,
we showed that KSR1-deficient cells exhibit an attenuation of
ERK activation with defects in cell proliferation.
Here we explored the role of KSR1 in NK cell-mediated
cytolysis. The killing of a target cell by a cytolytic T cell or NK
cell is a complicated process that involves cell polarization with
microtubule-dependent movement of cytolytic granules to an
area that is proximal to the contact surface or immunological
synapse (7, 33, 34, 48–50, 54). A variety of different signaling
molecules are also involved, including calcium (23), phospha-
tidylinositol-3,4,5-triphosphate (13, 17), and activation of the
ERK MAP kinase (6, 42, 56). Recently, the recruitment of
activated ERK to the immunological synapse (IS) has been
shown to be a feature of successful killing of a target by cyto-
toxic T lymphocytes (58).
How active ERK is recruited to the synapse is not known.
Since KSR1 is known to be recruited to the plasma membrane
by Ras activation (24), and since the immunological synapse is
one of the major sites of Ras activation (26, 41), it seemed
plausible to test the hypothesis that KSR1 recruitment to the
plasma membrane functions to recruit ERK to the immuno-
logical synapse and facilitate its activation. We found that
KSR1 was recruited to the immunological synapse and that
KSR1 appeared to be required for the localization of active
ERK at the contact site. As KSR1-deficient cells exhibit a
defect in killing, this suggests that KSR1 recruitment to the
synapse may be important in the cytolytic killing of target cells.
MATERIALS AND METHODS
Mice. KSR1-deficient mice (KSR1/) have been described previously (30).
All mice were housed under specific-pathogen-free conditions in the Washington
University animal facilities in accordance with institutional guidelines.
Cell cultures and antibodies. Jurkat E6.1 T cells, Daudi lymphoma B cells,
YAC-1 lymphoma cells, human K562 eritroblastoma cells, and RMAs and
RMAs-Rae1ε cells were grown in RPMI 1640 medium supplemented with 10%
fetal bovine serum (FBS). Human interleukin-2 (hIL-2)-dependent cell line
NK92 cells (15) were grown in RPMI 1640 medium supplemented with 10% FBS
and 100 U/ml of hIL-2. Mouse NK cells were purified by DX5 magnetic-
activated cell sorting enrichment (Miltenyi) and grown in hIL-2-containing me-
dium (5). Polyclonal rabbit anti-Grb2, rabbit anti-ERK2, rabbit anti-KSR1, and
mouse anti-Lck were obtained from Santa Cruz Biotechnology. Polyclonal rabbit
anti-phospho-ERK [pERK1/2 (Thr202/Tyr204)] and rabbit anti-phospho-
* Corresponding author. Mailing address: Department of Pathology
& Immunology, Washington University School of Medicine, St. Louis,
MO 63110. Phone: (314) 362-6311. Fax: (314) 362-8888. E-mail: shaw
@pathology.wustl.edu.
† Present address: Queensland Brain Institute, University of
Queensland, QBI Building 79, St. Lucia, QLD 4072, Australia.
 Published ahead of print on 12 January 2009.
1554
 o
n
 O
ctober 26, 2015 by University of Queensland Library
http://m
cb.asm
.org/
D
ow
nloaded from
 
MAPK/CDK substrates (PXSP) were obtained from Cell Signaling Technology.
Monoclonal anti-MAP kinase (diphosphorylated ERK1/2) and mouse anti--
tubulin were purchased from Sigma. Fluorescein isothiocyanate-labeled CD3ε
and phycoerythrin (PE)-NK1.1-labeled antibody were obtained from BD Bio-
sciences.
Generation of DNA constructs. Murine KSR1 (mKSR1) full-length cDNA was
subcloned into a pEYFP-N1 vector (Clontech). After EcoRI and NotI digestion,
mKSR1-YFP was cloned into a pMX retrovirus vector (31). The C359 and C362
mutants in the CA3 domain of mKSR1 (CCSS mutant) were generated using
PCR site-directed mutagenesis (Stratagene). The primers used for C359S were
5-G ATT TTT GGC GTG AAG AGC AAA CAC TGC AGG-3 and 5-CCT
GCA GTG TTT GCT CTT CAC GCC AAA AAT C-3; for C362S they were
5-GTG AAG AGC AAA CAC AGC AGG TTA AAA TGC CAT AAC-3 and
5-GTT ATG GCA TTT TAA CCT GCT GTG TTT GCT CTT CAC-3. The
integrity of all constructs was confirmed by automated sequencing.
Retroviral transduction. The Phoenix amphotropic retroviral packaging cell
line was kindly provided by Garry Nolan. After transfection using Lipofectamine
2000 (Life Technologies), cells were transferred to 32°C to allow accumulation of
virus in the supernatant. Virus-containing supernatant was harvested at 24 and
48 h after transfection and filtered through 0.45-m syringe filters (Millipore).
Jurkat cells were incubated with viral supernatant in the presence of 8 g/ml
of Polybrene (Sigma) and then centrifuged at 900  g. This step was repeated
after 4 h. Cells expressing yellow fluorescent protein (YFP) were sorted 3 to
5 days later on a Beckton Dickinson FACSVantage SE at the Flow Cytometry
Core Facility (Dept. of Pathology and Immunology, Washington University,
St. Louis, MO).
RNA interference and lentivirus production. KSR1 small hairpin RNA
(shRNA) and luciferase shRNA (control) constructs were generated using the
multifunctional lentivirus system (pFLRu lentivector; provided by Y. Feng and
G. D. Longmore). To generate human KSR1 shRNA fragments, two sequences
corresponding to nucleotides 1507 to 1530 and 2139 to 2157 were selected.
Primers (sequence 1 forward, GTG GAA AGG ACG AAA CAC CGC CTA
CTT CAT TCA TCA TAG ATA GCA TTC AAG AGA TGC TG; sequence 2
forward, GTG GAA AGG ACG AAA CAC CGC AGA CGT CTC TGG ACG
TCA ATT CAA GAG ATT GAT GT) were designated together with their
complementary counterparts and annealed by PCR to obtain shRNA fragments.
Joint PCR was carried out by using human U6 promoter forward primer (ACA
GAA TTC TAG AAC CCC AGT GGA AAG ACG CGC AG), shRNA reverse
primer, and mixed template (1 l of purified human U6 promoter and 2 l of
purified shRNA fragment). The PCR products were purified, digested with
XhoI/XbaI, and subcloned into pFLRu lentivector [pFLRu-(KSR1-shRNA)]. To
reconstitute KSR1 expression, mKSR1-YFP wild type and CCSS mutant were
subcloned into the pFLRu-KSR1#1-shRNA vector to create pFLRu-(KSR1#1-
shRNA)-mKSR1(WT)-YFP and pFLRu-(KSR1#1-shRNA)-mKSR1(CCSS)-
YFP, respectively. The integrity of all constructs was verified by automated
sequencing. For lentivirus production, subconfluent cultures of 293T cells were
transfected with packaging plasmid (pHR8.2R/pCMV-VSV-G at a ratio of
8:1) and pFLRu-derived plasmid (Y. Feng, H. Zhao, B. Wang, and G. D.
Longmore, submitted for publication) using Lipofectamine 2000. The lentivirus
infection of Jurkat cells was performed using the protocol described above, and
cells expressing the same level of YFP were sorted 3 to 5 days later.
Confocal imaging and immunofluorescence staining. To study the recruitment
of phosphorylated ERK (pERK) into the immunological synapse, purified NK
cells from wild-type (WT) or KSR1/ mice were mixed with equal amount of
carboxyfluorescein succinimidyl ester (CFSE)-preloaded YAC-1 target cells. Af-
ter centrifugation, cells were gently resuspended and placed onto poly-D-lysine-
coated glass slides for 10 min at 37°C. After aspiration of the medium, cells were
fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for 10 min.
Cells were permeabilized with 90% methanol for 30 min at 20°C, washed with
PBS containing 4% FBS, and incubated with mouse anti-pERK for 45 min at
room temperature. After washing, cells were incubated with Cy3-conjugated
anti-mouse immunoglobulin (Jackson ImmunoResearch Laboratories, Inc.) for
30 min at room temperature. To image the lytic granule polarization, the indi-
cated mouse NK cells were loaded with 100 nM Lysotracker (Molecular Probes)
for 20 min at 37°C. After washing, loaded mouse NK cells were mixed with
RMAs-Rae1ε target cells at a 1:1 ratio and flowed onto a parallel plate of flow
cells in a temperature-controlled chamber at 37°C. Images were taken over 0 to
20 min using a Zeiss LSM 510 laser-scanning confocal microscope (Oberkochen,
Germany) with 63 objective lenses. To study the recruitment of KSR1 and
pERK into the T-cell immunological synapse, transduced Jurkat cells were mixed
with an equal amount of Daudi B cells preloaded with or without staphylococcal
enterotoxin E (SEE). After centrifugation, cells were gently resuspended, placed
onto poly-L-lysine-coated glass slides for 5 min at 37°C, fixed, permeabilized, and
stained as described above. To quantitate the recruitment of KSR1-YFP or YFP
to the contact site, boxes were drawn at the contact area between the effector and
target cells, at the cytosol, and in a background area outside the cell by using the
Image J software program (NIH). The relative recruitment index (RRI) was
calculated as follows: (mean fluorescence intensity [MFI] at synapse  back-
ground)/(MFI at regions in the cytosol  background). For each experiment, the
percentage of Jurkat cells with an RRI of more than 1.1 was calculated. For
quantification of pERK translocation to the cell-cell contact area, the ratio of
MFI at the contact area versus an equivalent in the cytosol was calculated and a
ratio of more than 1.1 was scored as protein accumulation. At least 50 conjugates
were examined for each experiment, and three different experiments were per-
formed.
Cytotoxicity assays. Cytotoxic activity of mouse NK cells was tested against
YAC-1 or RMAs or RMAs-Rae1ε target cells using standard 4-h 51Cr release
assays (5). Where indicated, NK cells were preincubated with 10 M specific
MEK inhibitor (UO126; Calbiochem) at 37°C for 30 min. In all experiments,
spontaneous release did not exceed 10% of maximum release.
CFSE labeling and in vivo NK killing assay. The in vivo NK cell cytolytic
experiments were performed essentially as previously described (3). RMAs and
RMAs-Rae1ε cells (107) were labeled with 1 M (low peak) and 10 M (high
peak) CFSE (Molecular Probes) for 15 min at 37°C in RPMI 1640 medium
supplemented with 5% FBS. Labeling was blocked with 1:1 (vol/vol) FBS, and
cells were washed several times with RPMI complete medium. CFSE-loaded
cells were counted, mixed at a 1:1 ratio, and injected intraperitoneally (8  106
to 10  106 cells/mouse in a 300-l volume) in WT and KSR1/ mice. A small
sample of injection mix was acquired at the zero time point to record the ratio
between RMAs and RMAs-Rae1ε cells. At 24 h after injection, cells were
recovered by peritoneal lavage. After washing, the Rae1ε expression was mon-
itored by binding with a specific antibody (anti-Rae1ε antibody conjugated to
biotin; provided by Marina Cella) followed by the appropriate secondary anti-
body. The ratio between RMAs and RMAs-Rae1ε cells from CFSE-labeled cells
was determined by flow cytometry.
Cell conjugation assay. Target cells were loaded with 10 M CFSE for 15 min
at 37°C. NK cells from WT or KSR1/ mice were stained with PE-labeled
NK1.1 antibody (BD Biosciences). After washing, stained NK cells were mixed
with CFSE-loaded target cells at a 1:1 ratio, centrifuged, and incubated for 20
min at 37°C to form conjugates. After fixation in 4% paraformaldehyde in PBS
for 10 min, cells were analyzed by flow cytometry.
Flow cytometric measurement of intracellular ERK activation. T cells trans-
duced with the indicated lentivectors were mixed with SEE-pulsed Daudi B cells
at a 1:1 ratio, spun at 350  g for 10 s, and placed at 37°C for 5 min. T-cell–
antigen-presenting cell (APC) conjugates were then separated with ice-cold
PBS–2.5 mM EDTA and fixed with 4% paraformaldehyde for 10 min on ice.
Cells were permeabilized with 90% methanol for 30 min at 20°C, washed with
PBS containing 3% fetal bovine serum, and incubated with mouse anti-pERK for
45 min at room temperature. After washing, cells were incubated with phyco-
erythrin-labeled F(ab)2 anti-mouse immunoglobulin (Jackson ImmunoResearch
Laboratories, Inc.) for 30 min at room temperature. Staining was measured by
flow cytometry after gating for YFP-positive T cells and analyzed using FlowJo.
Cell stimulation, immunoprecipitation, and immunoblotting. Jurkat cells
transduced with the indicated lentivectors were starved for 1 h in RPMI 1640.
Daudi cells were loaded with 100 ng/ml of SEE (Toxin Technology, Inc.) for 30
min before mixing 2:1 (T cells:B cells) with T cells in RPMI medium. Cells were
gently centrifuged for 30 s and placed at 37°C for the indicated times. After
stimulation, the pellet was resuspended in ice-cold lysis buffer (0.1 M Tris base,
140 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mg/ml apoprotein, 1 mM phenyl-
methylsulfonyl fluoride, 1 mM sodium orthovanadate, and 50 mM sodium fluo-
ride). After centrifugation, proteins from cell lysates were resolved by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and analyzed
by immunoblotting with the indicated primary antibodies followed by incubation
with anti-mouse immunoglobulin G or anti-rabbit immunoglobulin G coupled to
horseradish peroxidase. To quantified the level of KSR1, whole-cell lysates from
Jurkat or NK92 cells transduced with the indicated lentivector were resolved by
SDS-PAGE. KSR1 protein bands were detected and quantified by immunoblot-
ting with the Odyssey system (Li-Cor). NK92 cells (5  106/sample) transduced
with the indicated lentivectors, after sorting, were IL-2 starved for 4 h in RPMI
1640 containing 5% FBS. Cells were incubated with an equal number of K562
target cells at 37°C for the indicated times. Cells were resuspended in ice-cold
lysis buffer and were centrifuged as described above. Cell lysates were analyzed
by immunoblotting with antibodies specific for phosphorylated ERK. In the
immunoprecipitation experiments, nucleus-free supernatant was incubated with
2 g/ml of monoclonal anti-Lck at 4°C for 60 min and then incubated with
protein A-Sepharose beads (Pharmacia) at 4°C for 90 min. After washing, Lck
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immunoprecipitates were resolved by SDS-PAGE, transferred to a membrane,
and analyzed by immunoblotting with the indicated antibodies.
Statistics. Statistical analyses were performed using a paired Student’s t test.
Differences that were statistically significant are noted in the figures below.
RESULTS
KSR1 is required for NK lytic activity. Previously we showed
that thymic and peripheral T-cell populations in KSR1/ mice
were similar to wild type (30). To determine the role of KSR1
in NK cell development, we measured the numbers of NK cells
by using antibodies to CD3 and NK1.1 in the spleens of wild-
type and KSR1/ mice (Fig. 1A). Flow cytometric analysis
showed that NK cells (NK1.1 CD3 cells) were normally
represented in spleens of KSR1/ mice (Fig. 1B). We also
observed that KSR1 deficiency did not affect the numbers of
NKT cells (NK1.1 CD3). Altogether, these data suggest that
NK cell development is normal in KSR1/ mice.
We then tested the role of KSR1 in NK cell killing. Splenic
NK cells from wild-type and KSR1-deficient mice were puri-
fied and NK lytic activity was tested by incubation with YAC-1
target cells. While wild-type NK cells efficiently killed YAC-1
cells (Fig. 2A), there was a significant reduction of killing when
using KSR1-deficient NK cells.
Since YAC-1 cell recognition is complex and involves several
different receptors (5), we also tested NK lytic activity medi-
ated by the NK receptor NKG2D. For these experiments we
used RMAs cells transfected with the mouse NKG2D ligand
Rae1ε (RMAs-Rae1ε) as targets. NK cells from KSR1-defi-
cient mice showed a significant reduction in cytolytic activity
(Fig. 2B) that was specific to NKG2D, as there was no killing
of RMAs cells lacking Rae1ε expression. Importantly, the re-
duction of NK cell cytotoxicity was not mediated by the de-
creased cell-cell adhesion, since the absence of KSR1 did not
affect the ability of NK cells to form conjugates with the indi-
cated target cells (Fig. 2C).
We confirmed the NK cell killing defect in vivo by injecting
wild-type and KSR1-deficient mice with RMAs and RMAs-
Rae1ε cells and monitoring tumor growth as previously de-
scribed (3). In this system, elimination of RMAs-Rae1ε cells is
mediated by NK cells in an NKG2D-dependent manner.
RMAs and RMAs-Rae1ε cells (107) were distinguished by
labeling with either 1 M (low staining) or 10 M (high stain-
ing) CFSE, respectively. Tumor cells were mixed at a 1:1 ratio
and injected intraperitoneally (8  106 to 10  106 cells/mouse
in a 300-l volume). A sample was measured before injection
to document the starting ratio between RMAs and RMAs-
Rae1ε cells (Fig. 2D and G). Twenty-four hours after injection,
cells were recovered by peritoneal lavage and stained with
anti-Rae1ε, and the ratio between RMAs and RMAs-Rae1ε
cells in the CFSE-labeled cells was determined by flow cytom-
etry. As expected (12), RMAs-Rae1ε cells were preferentially
eliminated in wild-type mice (Fig. 2E and G). In contrast,
elimination of RMAs-Rae1ε cells in KSR1/ mice was im-
paired (Fig. 2F and G). This demonstrates that KSR1 is re-
quired to mediate NK cell lytic activity in vivo.
NKG2D-induced lytic granule polarization is impaired in
KSR1/ mice. NK killing of the target cells is mediated by the
polarized release of lytic granules (13, 34). Since NK lytic
activity was impaired in the absence of KSR1, we investigated
whether KSR1 was required for lytic granule polarization. Pu-
rified NK cells from wild-type and KSR1/ mice were incu-
bated with Lysotracker to label lytic granules and then imaged
before and after conjugate formation with YAC-1 cells. Prior
to conjugation, lytic granules were randomly distributed in the
cytosol (Fig. 3A). After interaction with YAC-1 cells, lytic
granules of wild-type NK cells moved to a location near the site
of contact with the target cell (Fig. 3A and C). This was spe-
FIG. 1. Normal numbers of NK cells in KSR1/ mice. (A) Expres-
sion of KSR1 in splenocytes of WT and KSR1/ mice. Total cell
lysates of WT and KSR1/ mice were analyzed by immunoblotting
with anti-KSR1 antibody. Grb2 antibody was used as a loading control.
(B) Splenocytes of WT and KSR1/ mice were stained with NK1.1-PE
and CD3ε-fluorescein isothiocyanate antibody and analyzed by flow
cytometry. The dot blot is representative of three different experiments
(two mice/experiment).
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cific, as the polarized movement of lytic granules was inhibited
by using inhibitors of phosphatidylinositol 3 kinase (data not
shown). While the ability of KSR1-deficient NK cells to form
conjugates with YAC-1 cells was not affected, lytic granule
polarization was significantly reduced (Fig. 3B and C). These
results suggest that KSR1 is also important in lytic granule
polarization and that defects in granule polarization may be
responsible for defects in cytolytic killing.
FIG. 2. KSR1 is required for NK lytic activity in vitro and in vivo. (A and B) Cytotoxicity of WT and KSR1/ NK cells was tested against
YAC-1 cells (A) or RMAs and RMAs-Rae1ε target cells (B) in vitro. Purified NK cells (96% NK1.1 CD3ε) were IL-2 starved in RPMI
medium for 4 h before incubation with the indicated target cells. Where indicated, NK cells were preincubated with the MEK inhibitor UO126
(10 M). Data are representative of three independent experiments. E:T ratio, effector:target ratio. (C) Conjugate formation is normal in
KSR1-deficient cells. NK cells from WT or KSR1/ mice were stained with NK1.1-PE antibody and mixed with CFSE-loaded target cells. Cells
were allowed to form conjugates for 20 min at 37°C, fixed, and analyzed by flow cytometry. The bar graphs represent the percentages of NK1.1
CFSE double-positive cells from the total pool of NK1.1 cells. Data are represented as averages	 standard errors of the means of at least three
separate experiments. (D to G) NK killing assay in vivo. RMAs and RMAs-Rae1ε cells were labeled with different concentrations of CFSE and
mixed at a 1:1 ratio. (D) An aliquot of the cell mixture was analyzed before injection (time zero). (E and F) The cell mixture was injected
intraperitoneally into WT and KSR1/ mice. Twenty-four hours after injection, cells were recovered by peritoneal lavage. Rae1ε expression was
assessed by labeling with anti-Rae1ε antibody and examined by flow cytometry. The RMAs/RMAs-Rae1ε ratio was obtained by comparing high
and low CFSE-labeled cells. (G) Summary of RMAs/RMAs-Rae1ε ratios in six WT and six KSR1/ mice. Horizontal bars indicate the mean
ratios.
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pERK recruitment into the NK IS is impaired in KSR1/
mice. Recently it has been reported that pERK is recruited to
the immunological synapse of CD8 T cells (58). Since it is
postulated that the subcellular localization of signaling mole-
cules is mediated by scaffold molecules (18, 39, 45), we won-
dered whether KSR1 might be involved in ERK localization to
the IS.
We tested whether KSR1 plays a role in pERK localization
by first imaging pERK localization using NK cells from KSR1-
deficient mice. Purified NK cells from wild-type and KSR1/
mice were conjugated with YAC-1 cells. Cells were stained
with antibodies to pERK and analyzed by confocal microscopy.
While pERK was detectable in both wild-type and KSR1-
deficient NK cells, pERK localization at the synapses was in-
frequent in KSR1-deficient NK cells compared to wild-type
cells (Fig. 4A and B).
So that we could dissect the mechanism of KSR1 function,
we attempted to replicate these findings using Jurkat cells
where KSR1 expression was suppressed using lentiviruses ex-
pressing two different KSR1-specific shRNAs. Bulk sorting of
green fluorescent protein-positive cells showed that both
shRNAs resulted in over 70% inhibition of expression (Fig.
4C). pERK recruitment to the synapse was then analyzed by
forming conjugates between Jurkat cells and superantigen-
coated APCs (Fig. 4D and E). While pERK was easily detected
at the IS of conjugates formed using wild-type Jurkat cells (Fig.
4D, upper panels, and E), suppression of KSR1 expression
significantly impaired the recruitment of pERK to the IS (Fig.
4D, lower panels, and E). Similar results were obtained when
the same shRNAs were used in the human NK cell line NK92
(data not shown).
Consistent with results from KSR-deficient T cells (30), sup-
pression of KSR1 expression in the Jurkat cells attenuated
ERK activation (Fig. 5A). This suggested that our inability to
detect pERK at the synapse could be due to a generalized
defect in ERK activation. This seemed unlikely, as strong stain-
ing with the pERK antibody was easily detected in some of the
KSR1-deficient cells (Fig. 4D). Germain and coworkers have
demonstrated that ERK activation by the T-cell receptor is all
or none in individual CD8 T cells (1). What they found was
as the strength of T-cell receptor (TCR) signaling increases,
there is not a graded increase in ERK activation. Rather, at the
individual cell level, ERK is either fully activated in cells or not
activated at all. We, therefore, hypothesized that in the ab-
sence of KSR1, cells could still be activated but that the total
number of activated cells was lower. To confirm this, we used
flow cytometry to compare ERK activation in control versus
KSR1 shRNA-treated cells. As we expected, KSR1 shRNA
cells were able to activate ERK to levels similar to wild-type
cells but the number of cells that were activated was much
lower (Fig. 5B). This suggests that KSR1 functions to increase
the sensitivity of TCR-mediated activation of ERK. In addi-
tion, it suggests that the lack of pERK at the synapse is not due
to a generalized defect in ERK activation and supports the
hypothesis that KSR1 is required for the synapse localization
of pERK.
KSR1 recruitment is required for pERK accumulation into
the immunological synapse. To determine whether KSR1 itself
is recruited to the IS, Jurkat T cells were transduced with a
construct encoding KSR1 fused to YFP (KSR1-YFP). After
conjugation with superantigen-coated APCs, KSR1-YFP was
easily detected at the IS (Fig. 6A, lower panel, and B). As a
control, YFP by itself was distributed homogenously through-
out Jurkat cells with or without stimulation by SEE (Fig. 6C).
The KSR1-YFP recruitment was specific to T-cell activation,
as conjugation with APCs in the absence of superantigen did
FIG. 3. Lytic granule polarization is impaired in NK cells from
KSR1/ mice. (A and B) Time-lapse experiment, extracted from a
movie, showing representative images of the localization of lytic gran-
ules (red) in primary NK cells purified from spleens of WT (A) and
KSR1/ (B) mice and conjugated with CFSE-loaded YAC-1 target
cells (green; time in seconds). Bar, 5 m. (C) Lytic granule (LG)
polarization at the contact site with the indicated target cells was
quantitated after 5 min of incubation. Data represent the mean
(	standard error of the mean) percentage of conjugates from three
independent experiments with at least 40 conjugates. *, P 
 0.05.
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not result in any detectable KSR1 recruitment to the synapse
(Fig. 6A, upper panel, and B).
After Ras activation, KSR1 is recruited to the plasma mem-
brane via its CA3 domain (24). To verify that synapse recruit-
ment of KSR1 is responsible for pERK localization in the
synapse, we rescued KSR1-deficient Jurkat cells with either a
CA3-mutated KSR1-YFP construct or a wild-type KSR1-YFP
fusion. The CA3 domain has two conserved cysteine residues
that can be mutated to disrupt the structure of the domain and
its ability to bind to membranes (60). Cell sorting was used to
isolate a population of cells with similar expression levels (Fig.
7A). Since high-level expression of KSR1 is known to inhibit
ERK activation (20, 21), we first verified that the level of KSR1
expression in the cells that we isolated was able to restore ERK
activation. Flow cytometric analysis showed that the level of
wild-type KSR1 was sufficient to reconstitute ERK activation.
FIG. 4. Recruitment of pERK into the NK IS is impaired in KSR1-deficient mice. (A) Representative images showing the localization of pERK
(red) in primary NK cells purified from spleens of WT and KSR1/ mice that were conjugated with CFSE-loaded YAC-1 target cells (green). Bar,
5 m. (B) pERK accumulation at the NK IS was quantitated by dividing the percentage of cells with pERK at the NK IS by the total number of
pERK-positive cells imaged. Data represent the mean (	standard error of the mean) percentage of conjugates with an RRI (see Materials and
Methods) of 1.1, from three independent experiments with at least 30 conjugates. *, P 
 0.05. (C) KSR1 knockdown in Jurkat T cells.
Immunoblotting results are for KSR1 and Grb2 expression in Jurkat T cells (3.5  106 cells/lane) transduced with the indicated shRNA. KSR1
expression levels were compared to control shRNA Jurkat T cells. (D) pERK recruitment into the contact site is impaired in KSR1 knockdown
T cells. Representative differential interference contrast and Cy3 fluorescence images are shown for shRNA-expressing Jurkat T cells conjugated
with Daudi B cells preloaded with 100 ng/ml of superantigen. Bar, 5 m. (E) Percentage of conjugates with pERK recruited into the synapse, as
described for panel D. Quantitative analysis was done for pERK accumulation at the contact site from three independent experiments with at least
40 conjugates. Data represent the mean (	standard error of the mean) percentage of conjugates with an RRI of 1.1. *, P 
 0.05.
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Interestingly, the CA3 mutant was able to partially rescue ERK
activation, suggesting that KSR1 can facilitate ERK activation
in the absence of membrane recruitment (Fig. 7B).
We next tested whether cells expressing the CA3-mutated
KSR1-YFP could rescue pERK localization at the IS. Imaging
experiments showed that the wild-type KSR1-YFP was re-
cruited to the synapse and was able to rescue pERK localiza-
tion at the IS. In contrast, the CA3 mutant was not recruited to
the IS, nor was pERK detectable at the IS (Fig. 7C and D).
Together, these results demonstrate that KSR1 recruitment to
the IS is mediated by its CA3 domain and that KSR1 recruit-
ment to the IS is required for pERK localization at the immu-
nological synapse.
Phosphorylation of the Lck PXSP motif is regulated by
KSR1-mediated ERK activation. The requirement for active
ERK recruitment to the IS suggests that it is required for the
phosphorylation of proteins that are present in the synapse.
Since Lck is a known substrate for ERK during T-cell activa-
tion (47, 55, 57), we tested whether KSR1 was required for Lck
phosphorylation. A KSR1-specific shRNA-expressing lentivi-
rus was used to inhibit endogenous KSR1 expression in a
human NK cell line (Fig. 8A). We confirmed that suppression
of KSR1 reduced ERK activation in the human NK cell line
after stimulation with target cells (K562 cells) (Fig. 8B). Lck
immunoprecipitates were prepared from both wild-type and
KSR1 shRNA-expressing cells and blotted with an antibody
that recognizes ERK phosphorylation sites (PXSP). The in-
duction of Lck phosphorylation after target cell incubation was
reduced in KSR1 shRNA-treated NK cells compared to wild-
type cells (Fig. 8C). This supports the hypothesis that KSR1
recruitment of ERK facilitates the phosphorylation of ERK
substrates at the synapse.
DISCUSSION
Here we examined the role of KSR1 on the cytolytic func-
tion of NK cells and found that KSR1-deficient NK cells ex-
hibit a defect in killing. The defect appeared to be related to an
inability to polarize cytolytic granules. Since pERK recruit-
ment to the immunological synapse was recently reported dur-
ing the activation of CD8 T cells (58), and because ERK
activation is required for killing (6, 56), we explored the hy-
pothesis that pERK recruitment to the synapse might be facil-
itated by KSR1. Indeed, we found that in KSR1-deficient T
cells, pERK recruitment to the immunological synapse was
defective.
KSR1 is thought to function as a scaffold for the Ras/MAP
kinase pathway (18, 27, 28, 44). This scaffold molecule regu-
lates the intensity and duration of growth factor-induced ERK
activation to modulate a cell’s proliferative, oncogenic, and
adipogenic potential (20, 21, 40). It binds to all three kinases of
the ERK MAP kinase cascade, Raf-1, MEK, and ERK (19, 51,
53), and is recruited to the plasma membrane during Ras
activation, where it presumably facilitates the interaction be-
tween active Ras and Raf-1 (18, 28, 35). More recent data
suggest that KSR may have additional roles facilitating phos-
phorylation of the activation loop of Raf (9). Previously, we
showed that in KSR1-deficient T cells the activation of ERK
was still detectable but highly attenuated (30). We interpreted
this to mean that KSR1 is required for the efficient activation
of ERK.
In this study, we analyzed the ERK activation defect in more
detail. We previously used immunoblotting to measure ERK
activation (10, 30). This method, because it relies on the lysis of
millions of cells, averages the biochemical changes that occur
at a specific moment in time. Using such a method, an atten-
uation of ERK activation could be due to attenuation of ERK
activation in all cells or reflect a defect in ERK activation in
some but not others. Using flow cytometry to analyze ERK
activation at a single-cell level, we were surprised to find that
in KSR1-deficient cells, the defect of ERK activation only
affected some but not all cells. A small fraction of KSR1-
deficient cells showed levels of ERK activation that are similar
to wild-type cells.
Previous work had suggested that ERK activation in CD8
T cells is stochastic, that it is an all-or-none process (1). A weak
stimulus results in only a few cells that are fully activated and
FIG. 5. Antigen-induced T-cell activation is regulated by KSR1.
(A) ERK activation is impaired in KSR1 knockdown T cells. shRNA-
transduced Jurkat T cells were stimulated with superantigen-coated
Daudi cells (100 ng/ml) for the indicated times (in minutes) and ana-
lyzed for pERK1/2 by Western blotting. Blotting for -tubulin (-tub)
was used to demonstrate equal loading of each sample. (B) Suppres-
sion of KSR1 expression inhibits the number of activated Jurkat cells.
Representative histograms show the distribution of pERK as mea-
sured by flow cytometry of Jurkat T cells after activation by Daudi
preloaded with or without superantigen (10 ng/ml SEE). In the ab-
sence of stimulation, no shift in the x axis of histograms was observed
in either control or KSR1 shRNA-expressing Jurkat cells. Notably,
after stimulation the change in area under the peak indicates that ERK
activation was observed in a higher number of control shRNA cells.
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as the strength of a stimulus is increased, more and more cells
show full ERK activation. In support of this idea, we found that
the attenuation of ERK activation seen in KSR1-deficient cells
is due to decreased numbers of activated cells, suggesting that
KSR1 functions by lowering the threshold stimulus required
for the stochastic activation of ERK. We speculate that by
helping to recruit the Raf/MEK/ERK module to active Ras,
KSR1 may function to enhance the activation of the pathway
(22).
It is intriguing to speculate that recruitment of KSR1 and
the ERK MAP kinase cascade to the immunological synapse
may have functions in addition to simply facilitating ERK ac-
tivation. By holding active ERK at the immunological synapse,
KSR1 may function to allow ERK to phosphorylate specific
substrates at the plasma membrane essential for T-cell func-
tion. For example, it has been proposed that ERK phosphor-
ylation of Lck may play an important role in facilitating a
positive feedback loop that is important for enhancing T-cell
activation (47). Our immunoprecipitation data indicated that
ERK-dependent phosphorylation of the PXSP motif in Lck
was diminished after KSR1 suppression, supporting the role of
KSR1 on ERK substrate phosphorylation into the synapse.
Other important substrates at the immunological synapse in-
clude stathmin, a molecule that plays a key role in helping to
regulate microtubule polymerization (4). It seems possible that
the granule polarization defect seen in the KSR1-deficient cells
FIG. 6. KSR1 is recruited into the immunological synapse. (A) Representative differential interference contrast, YFP, and Cy3 fluorescence
images of Jurkat T cells expressing KSR1-YFP after conjugation with Daudi B cells loaded with or without SEE (100 ng/ml). In the absence of
SEE (-SEE), ERK (red) is not phosphorylated and KSR1 (green) is not recruited into the contact site. In the far right panel, the location of pERK
is shown in false color. Bar, 5 m. (B) KSR1 and pERK accumulation at the contact site was quantitated from three independent experiments with
at least 50 conjugates. Data are represented as the average (	standard error of the mean) of conjugates with an RRI of 1.1 (see Materials and
Methods). (C) Representative differential interference contrast, YFP, and Cy3 fluorescence images of Jurkat T cells expressing YFP conjugated
with Daudi B cells and stimulated as for panel A. Images are representative of two independent experiments with at least 30 conjugates.
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is due to defects in ERK phosphorylation of critical substrates
at the immunological synapse.
The localization of the MAP kinase cascade at different sites
in the cell has been suggested to play an important role in
T-cell biology (26). While it was originally thought that Ras
activation of the MAP kinase cascade could only be initiated at
the plasma membrane, it has now become clear that different
Ras isoforms are localized and activated at distinct intracellu-
lar membranes (2, 8, 37). At steady state, while K-Ras is mainly
localized to the plasma membrane and N-Ras and H-Ras are
FIG. 7. KSR1 recruitment affected pERK accumulation into the contact site and antigen-induced T-cell activation. (A) Immunoblotting for
KSR1 expression in Jurkat T cells (600  103 cells/lane) transduced with control shRNA, KSR1#1 shRNA, or rescue KSR1#1 shRNA lentivector
containing KSR1(CCSS)-YFP or KSR1(WT)-YFP. Transduced Jurkat T cells with rescued CCSS mutant and WT KSR1 were sorted to achieve
a pool of cells with similar expression levels (low and high) of KSR1-YFP. The KSR1 expression level compared to control shRNA transduced
Jurkat T cells is indicated. (B) Representative histograms of the distribution of pERK as measured by flow cytometry of the indicated transduced
Jurkat T cells after activation by Daudi cells preloaded without (-SEE) or with 1,000 ng/ml of superantigen (SEE). (C) KSR1 is required for
pERK recruitment into the IS. Images shown are representative of differential interference contrast (DIC), YFP (KSR1), and Cy3 (pERK)
fluorescence images of KSR1#1 shRNA-KSR1(WT)-YFP or KSR1#1 shRNA-KSR1(CCSS)-YFP Jurkat T cells conjugated with Daudi B cells
preloaded with SEE (100 ng/ml). In the far right panel, the location of pERK is shown in false color. Bar, 5 m. (D) Quantitative analysis of KSR1
and pERK accumulation levels at the contact site from three independent experiments with at least 40 conjugates. Data are presented as the
average (	standard error of the mean) of conjugates with an RRI (see Materials and Methods) of 1.1.
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mainly localized to the Golgi apparatus (36). Philips and co-
workers showed that TCR stimulation alone resulted mainly in
Golgi complex activation of Ras, while costimulation with anti-
LFA-1 allowed for plasma membrane and Golgi complex ac-
tivation (25). In other systems, Ras signaling has been shown to
occur on endosomes as well as in endoplasmic reticulum mem-
branes (14, 38). Inherent in these studies is the idea that
localized Ras signaling is important in the activation of loca-
tion-specific effectors, but it is also possible that this plays a
role in localizing active ERK close to the location-specific
substrates. Unfortunately, in these studies, the localization of
active ERK was not determined.
Whether KSR1 localizes to sites other than the plasma
membrane is not yet known. It would be interesting if KSR1
and KSR2 were recruited to distinct membranes. Unfortu-
nately, little is known about the expression pattern of KSR2.
Probe sets for KSR2 are available on commercial microarrays
for both human and mouse, but there are no data documenting
any level of expression in any tissue. In our own hands, we have
been unable to detect KSR2 message using a variety of differ-
ent methods in any lymphoid or myeloid compartment.
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